MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)

Exclusion Criteria

• •Patient is pregnant or breast-feeding, or is a female expecting to conceive within the projected duration of the study
• •Patient has basilar or hemiplegic migraine headache, hepatitis or psychiatric conditions
• •Patient was older than 50 years of age at migraine onset
• •History of gastric or small intestinal surgery or has a disease that causes malabsorption
• •Patient has heart attack, unstable angina, coronary artery bypass surgery or other revascularization procedure, stroke, or transient ischemic attack 3 months before starting the study
• •Currently participating or has participated in a study with an investigational compound or device within 30 days of starting the study
• •Currently participating in a study with MK-0974 or MK-3207